MGAT5 抗体 (AA 201-300) (FITC)
Quick Overview for MGAT5 抗体 (AA 201-300) (FITC) (ABIN758673)
抗原
See all MGAT5 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 201-300
- 
                                            交叉反应
- 人
- 
                                            预测反应
- Mouse,Rat,Dog,Chicken,Rabbit
- 
                                            纯化方法
- Purified by Protein A.
- 
                                            免疫原
- KLH conjugated synthetic peptide derived from human MGAT5
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        IF(IHC-P) 1:50-200
 IF(IHC-F) 1:50-200
 IF(ICC) 1:50-200
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 1 μg/μL
- 
                                            缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - MGAT5 (Mannosyl (Alpha-1,6-)-Glycoprotein beta-1,6-N-Acetyl-Glucosaminyltransferase (MGAT5))
- 
                                            别名
- MGAT5
- 
                                            背景
- 
                        Synonyms: 6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A, 6-N-acetylglucosaminyltransferase, Alpha 1,36 mannosylglycoprotein, Alpha 1,6 mannosylglycoprotein 6 beta N acetylglucosaminyltransferase, Alpha mannoside beta 1,6 N acetylglucosaminyltransferase, Alpha mannoside beta 1,6 N acetylglucosaminyltransferase, Alpha- mannoside beta-1,6-N-acetylglucosaminyltransferase, Alpha-1, alpha-1,36-mannosylglycoprotein, Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase, Alpha-mannoside beta-1, alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase, Beta 1,6 N acetyl glucosaminyltransferase, beta-1,6-N-acetyl-glucosaminyltransferase, GGNT5, GlcNAc T V, GlcNAc-T V, GNT V, GNT VA, GNT-V, GNTV, GNTVA, Mannoside acetylglucosaminyltransferase 5, Mannosyl alpha 1,6 glycoprotein beta 1,6 N acetyl glucosaminyltransferase, mannosyl alpha-1,6--glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, Mgat5, MGT5A_HUMAN, N acetylglucosaminyl transferase V, N acetylglucosaminyltransferase V mannosyl alpha 1,6 glycoprotein, N-acetylglucosaminyl-transferase V, N-acetylglucosaminyltransferase V. Background: MGAT5 is a mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, a glycosyltransferase involved in the synthesis of protein-bound and lipid-bound oligosaccharides. Alterations of the oligosaccharides on cell surface glycoproteins cause significant changes in the adhesive or migratory behavior of a cell. Increase in the encoded protein's activity may correlate with the progression of invasive malignancies. 
- 
                                            基因ID
- 4249
 抗原
- 
                    
 
                                     
                                     
                                    